Drugs · acquisition-cost intelligence
FLOVENT DISKUS
fluticasone propionate· ingredient fluticasoneCorticosteroids· FLUTICASONE PROPIONATE 100 ug/1; FLUTICASONE PROPIONATE 250 ug/1; FLUTICASONE PROPIONATE 50 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$2.12
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluticasone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| fluticasone propionate | $0.35931 | −$1.76 |
| Fluticasone Propionate | $0.56876 | −$1.55 |
| 24 Hour Allergy Nasal | $0.68437 | −$1.43 |
| fluticasone propionate | $3.14 | +$1.02 |
| Arnuity Ellipta | $6.65 | +$4.54 |
| Fluticasone Propionate HFA | $12.55 | +$10.44 |
Medicare Part D coverage · CY2026
On 47 plan formularies · typical tier 3
Prior auth 0% · Step therapy 11% · Quantity limit 79% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.